Psoriasis is a long-lasting, non-contagious, autoimmune disease characterised by raised areas of abnormal skin. These areas are red or, in some people with darker skin, purple. The skin becomes dry, itchy and scaly. Psoriasis may be localised or it may spread more widely, even spreading completely to the entire body.
Showing 1–12 of 23 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price | |
---|---|---|---|---|---|---|---|---|---|---|
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
– |
4 mg |
-80°C |
03/2023 |
743,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
06/2023 |
743,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
09/2018 |
675,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2018 |
675,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2019 |
675,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2019 |
675,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
07/2019 |
675,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
12/2019 |
675,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
03/2020 |
743,00Â € |
||
TNF alpha |
Biosimilar , Fusion protein |
Benepali® |
50 mg/mL |
– |
4 mg |
-80°C |
11/2023 |
240,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
11/2019 |
285,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
285,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2020 |
285,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
03/2021 |
285,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
12/2020 |
285,00Â € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
yes |
6 mg |
-80°C |
11/2022 |
535,00Â € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
12/2017 |
378,00Â € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
02/2019 |
378,00Â € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6mg |
-80°C |
12/2022 |
409,00Â € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
03/2018 |
378,00Â € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
09/2019 |
378,00Â € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
06/2018 |
378,00Â € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
12/2018 |
378,00Â € |
Let us know about your inquiry details and we’ll contact you shortly.